Vancomycin Market

Vancomycin is an effective and safe antibiotic in the treatment of severe infections caused by methicillin-resistant staphylococcus aureus, methicillin-resistant coagulase-negative staphylococcus and enterococcus, including sepsis, pulmonary infection and skin and soft tissue infection.

Vancomycin Market contains market size and forecasts of Vancomycin in global, including the following market information:

Global Vancomycin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Vancomycin Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Vancomycin companies in 2021 (%)

The global Vancomycin market was valued at 343.6 million in 2021 and is projected to reach US$ 479.1 million by 2028, at a CAGR of 4.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Daptomycin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vancomycin include Pfizer, Eli Lilly and Company, CJ CheilJedang, Xellia Pharmaceuticals ApS, VIANEX, Alchemia Limited, Alvogen, Aphios Corporation and Cellceutix Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Vancomycin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vancomycin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Vancomycin Market Segment Percentages, by Type, 2021 (%)

Daptomycin

Linezolid

Quinupristin

Ampicillin

Chloramphenicol

Others

Global Vancomycin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Vancomycin Market Segment Percentages, by Application, 2021 (%)

Sepsis

Lung Infection

Skin Soft Tissue Infection

Colitis & Intestinal Inflammation

To Prevent Infection

Global Vancomycin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Vancomycin Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vancomycin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Vancomycin revenues share in global market, 2021 (%)

Key companies Vancomycin sales in global market, 2017-2022 (Estimated), (KG)

Key companies Vancomycin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Pfizer

Eli Lilly and Company

CJ CheilJedang

Xellia Pharmaceuticals ApS

VIANEX

Alchemia Limited

Alvogen

Aphios Corporation

Cellceutix Corporation

Enanta Pharmaceuticals

Helix BioMedix

LegoChem Biosciences

Lytix Biopharma

MGB Biopharma Limited

Microbiotix.

MicuRx Pharmaceuticals

Nabriva Therapeutics

NovaBay Pharmaceuticals

NovoBiotic Pharmaceuticals

Oragenics

Sealife Pharma

Taiwan Zhengde Pharmaceutical

Zhejiang Pharmaceutical

Zhejiang Haizheng Pharmaceutical

North China Pharmaceutical

Shenwei Pharmaceutical